Literature DB >> 19755275

FDA panel, 7 and 8 December 2006 - The impact on our practice and research.

Patrick W Serruys1.   

Abstract

Year:  2007        PMID： 19755275

Source DB:  PubMed          Journal:  EuroIntervention        ISSN： 1774-024X            Impact factor:   6.534


× No keyword cloud information.
  4 in total

Review 1.  Single or dual antiplatelet therapy after PCI.

Authors:  Yosuke Miyazaki; Pannipa Suwannasom; Yohei Sotomi; Mohammad Abdelghani; Karthik Tummala; Yuki Katagiri; Taku Asano; Erhan Tenekecioglu; Yaping Zeng; Rafael Cavalcante; Carlos Collet; Yoshinobu Onuma; Patrick W Serruys
Journal:  Nat Rev Cardiol       Date:  2017-02-09       Impact factor: 32.419

Review 2.  New concepts in the design of drug-eluting coronary stents.

Authors:  Scot Garg; Christos Bourantas; Patrick W Serruys
Journal:  Nat Rev Cardiol       Date:  2013-02-19       Impact factor: 32.419

Review 3.  Antiplatelet therapy after percutaneous coronary intervention: current status and future perspectives.

Authors:  Masahiro Natsuaki; Shinjo Sonoda; Goro Yoshioka; Hiroshi Hongo; Tetsuya Kaneko; Kuninobu Kashiyama; Kensuke Yokoi; Yutaka Hikichi; Koichi Node
Journal:  Cardiovasc Interv Ther       Date:  2022-03-03

4.  Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial.

Authors:  Elvin Kedhi; Enrico Fabris; Martin van der Ent; Pawel Buszman; Clemens von Birgelen; Vincent Roolvink; Alexander Zurakowski; Carl E Schotborgh; Jan C A Hoorntje; Christian Hasbø Eek; Stéphane Cook; Marco Togni; Martijn Meuwissen; Niels van Royen; Ria van Vliet; Hans Wedel; Ronak Delewi; Felix Zijlstra
Journal:  BMJ       Date:  2018-10-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.